Organovo Holdings Inc (ONVO)
0.967
-0.06
(-6.12%)
USD |
NASDAQ |
May 06, 16:00
0.967
0.00 (0.00%)
After-Hours: 20:00
Organovo Holdings Net Income (Quarterly): -3.604M for Dec. 31, 2023
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -3.604M |
| September 30, 2023 | -3.994M |
| June 30, 2023 | -4.028M |
| March 31, 2023 | -7.459M |
| December 31, 2022 | -3.264M |
| September 30, 2022 | -3.321M |
| June 30, 2022 | -3.215M |
| March 31, 2022 | -1.911M |
| December 31, 2021 | -3.50M |
| September 30, 2021 | -3.505M |
| June 30, 2021 | -2.532M |
| March 31, 2021 | -2.596M |
| December 31, 2020 | -2.511M |
| September 30, 2020 | -8.95M |
| June 30, 2020 | -2.769M |
| March 31, 2020 | -2.723M |
| December 31, 2019 | -3.37M |
| September 30, 2019 | -6.294M |
| June 30, 2019 | -6.323M |
| March 31, 2019 | -6.983M |
| December 31, 2018 | -6.399M |
| September 30, 2018 | -5.837M |
| June 30, 2018 | -7.416M |
| March 31, 2018 | -7.449M |
| December 31, 2017 | -7.791M |
| Date | Value |
|---|---|
| September 30, 2017 | -9.461M |
| June 30, 2017 | -10.10M |
| March 31, 2017 | -10.66M |
| December 31, 2016 | -9.581M |
| September 30, 2016 | -9.442M |
| June 30, 2016 | -8.767M |
| March 31, 2016 | -8.372M |
| December 31, 2015 | -10.46M |
| September 30, 2015 | -11.26M |
| June 30, 2015 | -8.491M |
| March 31, 2015 | -7.798M |
| December 31, 2014 | -6.993M |
| September 30, 2014 | -8.858M |
| June 30, 2014 | -6.433M |
| March 31, 2014 | -6.482M |
| December 31, 2013 | -5.208M |
| September 30, 2013 | -10.39M |
| June 30, 2013 | -3.771M |
| December 31, 2012 | -9.565M |
| September 30, 2012 | 38.48M |
| June 30, 2012 | -35.39M |
| March 31, 2012 | -37.08M |
| December 31, 2011 | -0.0435M |
| September 30, 2011 | -0.0234M |
| June 30, 2011 | -0.0694M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Quarterly) Range, Past 5 Years
-8.95M
Minimum
Sep 2020
-1.911M
Maximum
Mar 2022
-3.993M
Average
-3.37M
Median
Dec 2019
Net Income (Quarterly) Benchmarks
| Marinus Pharmaceuticals Inc | -41.77M |
| Cartesian Therapeutics Inc | -177.66M |
| Adial Pharmaceuticals Inc | -1.920M |
| Longeveron Inc | -6.028M |
| Viracta Therapeutics Inc | -13.76M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 0.005M |
| Total Expenses (Quarterly) | 3.685M |
| EPS Diluted (Quarterly) | -0.40 |
| Enterprise Value | 5.046M |
| Profit Margin (Quarterly) | -72.08K% |
| Earnings Yield | -224.4% |
| Normalized Earnings Yield | -226.21 |